What lessons can be learned from Υδ T cell-based cancer immunotherapy trials?

著录项

• 来源
  《中国免疫学杂志（英文版）》 |2013年第1期|35-41|共7页
• 作者

  Jean-Jacques Fournié; Hélène Sicard; Mary Poupot; Christine Bezombes; Amandine Blanc; Francois Romagné; Loic Ysebaert; Guy Laurent;

  展开▼
• 作者单位

  INSERM UMR1037-Cancer Research Center of Toulouse, Toulouse, France;

  University of Toulouse, Toulouse, France;

  ERL5294 CNRS, BP3028, Hospital Purpan, Toulouse,France;

  Innate Pharma, Marseilles, France;

  INSERM UMR1037-Cancer Research Center of Toulouse, Toulouse, France;

  University of Toulouse, Toulouse, France;

  ERL5294 CNRS, BP3028, Hospital Purpan, Toulouse,France;

  INSERM UMR1037-Cancer Research Center of Toulouse, Toulouse, France;

  University of Toulouse, Toulouse, France;

  ERL5294 CNRS, BP3028, Hospital Purpan, Toulouse,France;

  INSERM UMR1037-Cancer Research Center of Toulouse, Toulouse, France;

  University of Toulouse, Toulouse, France;

  ERL5294 CNRS, BP3028, Hospital Purpan, Toulouse,France;

  Innate Pharma, Marseilles, France;

  INSERM UMR1037-Cancer Research Center of Toulouse, Toulouse, France;

  University of Toulouse, Toulouse, France;

  ERL5294 CNRS, BP3028, Hospital Purpan, Toulouse,France;

  Department of Hematology, Hospital Purpan, Toulouse, France;

  INSERM UMR1037-Cancer Research Center of Toulouse, Toulouse, France;

  University of Toulouse, Toulouse, France;

  ERL5294 CNRS, BP3028, Hospital Purpan, Toulouse,France;

  Department of Hematology, Hospital Purpan, Toulouse, France;

  展开▼
• 原文格式 PDF
• 正文语种 chi
• 中图分类
• 关键词